0.8404
Aditxt Inc stock is traded at $0.8404, with a volume of 213.34K.
It is down -4.77% in the last 24 hours and down -72.71% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$0.8825
Open:
$0.9
24h Volume:
213.34K
Relative Volume:
0.15
Market Cap:
$1.49M
Revenue:
$212.10K
Net Income/Loss:
$-40.19M
P/E Ratio:
-0.000158
EPS:
-5313.2836
Net Cash Flow:
$-13.92M
1W Performance:
+0.71%
1M Performance:
-72.71%
6M Performance:
-99.34%
1Y Performance:
-99.98%
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ADTX
Aditxt Inc
|
0.8404 | 1.57M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aditxt Inc Stock (ADTX) Latest News
Risk Off: Is Aditxt Inc stock cheap at current valuationEarnings Recap Report & Verified Momentum Stock Ideas - moha.gov.vn
Aditxt shares fall on 1-for-250 reverse stock split - MSN
Will Aditxt Inc. stock benefit from sector rotationExit Strategy Tips & High Yield Investment Tips - bollywoodhelpline.com
CEO Change: Will Aditxt Inc stock reach Wall Street targetsJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - moha.gov.vn
BRADY BRIAN MICHAEL Insider Trades - Nasdaq
How Aditxt Inc. stock performs in rate cut cyclesPortfolio Risk Report & Stock Market Timing Techniques - Улправда
Why Aditxt Inc. stock is favored by top institutionsMarket Sentiment Summary & Daily Entry Point Trade Alerts - DonanımHaber
Will Aditxt Inc. stock reach Wall Street targets2025 EndofYear Setup & Expert Verified Stock Movement Alerts - Bölüm Sonu Canavarı
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Analyzing Aditxt’s Stunning Stock Rally - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aditxt’s Stock Skyrockets on Growth Vision and Market Confidence - timothysykes.com
Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Benzinga
ADTX Stock Rallies Amid Strategic Shifts - timothysykes.com
Stock Market Today: S&P 500, Dow Futures Gain As Jobs Data Weighs On Outlook—Lennar, Micron Technology, Children's Place In Focus (UPDATED) - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionAditxt (NASDAQ:ADTX), Akanda (NASDAQ:AKAN) - Benzinga
Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025 - ts2.tech
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket - Benzinga
What Sparked Aditxt (ADTX) Stock's 52% After‑Hours Surge? - Sahm
Aditxt (NASDAQ: ADTX) special meeting on financings, equity plans and large reverse split range - Stock Titan
MSN Money - MSN
ADTX (Nasdaq: ADTX) raises ATM common stock capacity to $20M - Stock Titan
Market Rankings: Will Aditxt Inc stock gain from strong economy2025 Performance Recap & Community Trade Idea Sharing Platform - moha.gov.vn
Aditxt faces Nasdaq non-compliance notice - MSN
Can Aditxt Stock Recover If Markets Fall? - Trefis
Aditxt Faces Nasdaq Non-Compliance Notice - TipRanks
Aditxt (ADTX) Stock on December 5, 2025: BitXbio Pivot, Reverse Split and Survival Risk Explained - ts2.tech
Aditxt (ADTX) Stock Analysis Report | Financials & Insights - Benzinga
Will Aditxt Inc. stock recover faster than peersWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
Aditxt, Inc.,Aditxt, Inc. LIVE, Aditxt, Inc. price NSE, Aditxt, Inc. price BSE, Aditxt, Inc.price today, Live Price today - Markets Mojo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Best Penny Stocks To Watch TodayNovember 29th - MarketBeat
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Promising Penny Stocks To ConsiderNovember 30th - MarketBeat
Penny Stocks To Follow NowNovember 28th - MarketBeat
Growth or Bubble? Evaluating Aditxt’s Rapid Rise - timothysykes.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Aditxt’s Bold Strategy Spurs Market Buzz - StocksToTrade
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aditxt Stock Faces Tumultuous Times Ahead - timothysykes.com
Morning Market Movers: SMX, ADTX, TMC, CDT See Big Swings - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
ADTX Chief M&A Officer reports small 1-share insider sale - Stock Titan
Aditxt, Inc.Common Stock (NQ: ADTX - Markets Financial Content
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
With Aditxt Stock Sliding, Have You Assessed The Risk? - Trefis
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aditxt Inc Stock (ADTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pankovcin Corinne | Chief M&A Officer |
Nov 25 '25 |
Sale |
3.20 |
1 |
3 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):